TITLE

Drinking from the fountain of promise: biomarkers in the surveillance of Barrett's oesophagus—the glass is half full!

AUTHOR(S)
Preston, S. L.; Jankowski, J. A.
PUB. DATE
October 2006
SOURCE
Gut;Oct2006, Vol. 55 Issue 10, p1377
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article comments on the usefulness of biomarkers in the study of Barrett's esophagus. Barrett's esophagus is an acquired premalignant condition that is a precursor to esophageal adenocarcinoma. One biomarker method being described is the utilization of p53 immunostaining in esophageal biopsies. The researchers discovered that biomarker levels are higher in adenomatous than the metaplastic Barrett's esophagus tissue.
ACCESSION #
22659573

 

Related Articles

  • Preservation of Gastric Acid Secretion May Be Important for the Development of Gastroesophageal Junction Adenocarcinoma in Japanese People, Irrespective of the H. pylori Infection Status. Inomata, Yoshifumi; Koike, Tomoyuki; Ohara, Shuichi; Abe, Yasuhiko; Sekine, Hitoshi; Iijima, Katsunori; Ariizumi, Ken; Yamagishi, Hatsushi; Kitagawa, Yasushi; Imatani, Akira; Shimosegawa, Tooru // American Journal of Gastroenterology;May2006, Vol. 101 Issue 5, p926 

    BACKGROUND: We have previously reported that Helicobacter pylori infection prevents reflux esophagitis (RE) and Barrett's esophagus (BE) by decreasing gastric acid secretion. Gastroesophageal (GE) junction adenocarcinoma, including Barrett's adenocarcinoma, has been thought to be a complication...

  • Screening and Surveillance for Barrett Esophagus in High-Risk Groups: A Cost-Utility Analysis. Inadomi, John M.; Sampliner, Richard; Lagergren, Jesper; Lieberman, David; Fendrick, Mark; Vakil, Nimish // Annals of Internal Medicine;2/4/2003, Vol. 138 Issue 3, p176 

    Determines the cost-effectiveness of screening for Barrett esophagus in patients with gastroesophageal reflux disease (GERD). Use of a decision analytic model; Study of 50-year-old white men with symptoms of GERD; Cost-effectiveness of screening 50-year-old men with symptoms of GERD to detect...

  • Endoscopy for Barrett's Esophagus and Esophageal Adenocarcinoma. Shaheen, Nicholas // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2060 

    Focuses on the endoscopic screening for Barrett's esophagus and esophageal adenocarcinoma in patients with reflux symptoms. Relation of gastroesophageal reflux disease with cancer; Benefits from medical screening tests; Prevalence of Barrett's esophagus in the U.S.

  • Screening for Barrett's Esophagus. DeVault, Kenneth R. // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2061 

    Focuses on the endoscopic screening of Barrett's esophagus. Association between esophageal adenocarcinoma and gastroesophageal reflux disease; Biopsy of esophageal mucosa required for the diagnosis of Barrett's esophagus; Health risk of the routine biopsy of a squamocolumnar junction.

  • Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma: a review of the evidence. Shaheen, Nicholas J.; Provenzale, Dawn; Sandler, Robert S. // American Journal of Gastroenterology;Jun2002, Vol. 97 Issue 6, p1319 

    Esophageal adenocarcinoma is a rare cancer that is increasing rapidly in incidence. Because gastroesophageal reflux disease (GERD) is a risk factor for the development of this cancer, endoscopic screening of individuals with GERD symptoms and endoscopic surveillance of those who are found to...

  • Heartburn → Adenocarcinoma of Esophagus. Young, R. L.; Thompson, Jon S. // American Journal of Gastroenterology;Aug1999, Vol. 94 Issue 8, p2007 

    Provides information on a Swedish study which evaluated the association of gastroesophageal reflux and esophageal adenocarcinoma. Patients that were interviewed in the study; Persons with the highest odds ratio for developing esophageal adenocarcinoma; Need for on-going re-examination of the...

  • Meta-Analysis: Obesity and the Risk for Gastroesophageal Reflux Disease and Its Complications. Hampel, Howard; Abraham, Neena S.; El-Serag, Hashem B. // Annals of Internal Medicine;8/2/2005, Vol. 143 Issue 3, p199 

    Background: The association of body mass index and gastroesophageal reflux disease (GERD), including its complications (esophagitis, Barrett esophagus, and esophageal adenocarcinoma), is unclear. Purpose: To conduct a systematic review and meta-analysis to estimate the magnitude and determinants...

  • Healing of Oesophagitis. Rodrigo, L. // Drugs;2005 Supplement 1, Vol. 65, p51 

    The reflux oesophagitis treatment aims to achieve a rapid and sustained symptom relief and a high percentage of lesion healing, apart from preventing the relapses and complications of the disease. For that purpose it is essential to maintain the oesophagic pH above 4 for as long as possible...

  • Maintenance Therapy in Gastro-oesophageal Reflux Disease. Bixquert, Miguel // Drugs;2005 Supplement 1, Vol. 65, p59 

    Gastro-oesophageal reflux disease (GORD) is a chronic condition. Symptom control and the maintenance of healing of erosive oesophagitis, if present, are important topics. In patients responding to a proton pump inhibitor (PPI) and showing no treatment symptoms it is appropriate to consider...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics